Skip to main content

Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF

Publication ,  Journal Article
Van Diepen, S; Hellkamp, AS; Patel, MR; Becker, RC; Breithardt, G; Halperin, JL; Hankey, GJ; Nessel, CC; Singer, DE; Berkowitz, SD; Califf, RM ...
Published in: CIRCULATION
November 20, 2012

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Van Diepen, S., Hellkamp, A. S., Patel, M. R., Becker, R. C., Breithardt, G., Halperin, J. L., … Mahaffey, K. W. (2012). Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION, 126(21).
Van Diepen, Sean, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Gunter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, et al. “Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF.” CIRCULATION 126, no. 21 (November 20, 2012).
Van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Halperin JL, et al. Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION. 2012 Nov 20;126(21).
Van Diepen, Sean, et al. “Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.
Van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Halperin JL, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology